REGENERON PHARMAC.DL-,001/ US75886F1075 /
21.05.2024 8:16:38 | Изменение +2.0000 | Объем сделки | Бид13:30:00 | Предложение13:30:00 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
901.2000EUR | +0.22% | 0 Оборот: 0.0000 |
898.4000Величина цены спроса: 10 | 909.4000Величина цены предложения: 10 | 100.2 млрдEUR | - | - |
GlobeNewswire
14:15
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
GlobeNewswire
14:15
BYD’s Official Dealership in Mexico, Owned and Operated by Grupo Fame, Selects Blink Charging for EV...
GlobeNewswire
14:08
Onfolio Holdings Inc. Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14:05
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Co...
GlobeNewswire
14:05
Pyxis Tankers Announces Joint Venture Agreement to Acquire Modern Dry-Bulk Vessel, Expansion of Com...
GlobeNewswire
14:02
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire
14:00
Allegro MicroSystems Expands Isolated Gate Driver Portfolio with Power-Thru Combo Chip
GlobeNewswire
14:00
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...
GlobeNewswire
14:00
Axalta Announces Partnership with Solera, a Global Leader in Vehicle Lifecycle Management
GlobeNewswire
14:00
REE Unveils a Next Gen Software-Driven Electric Commercial Vehicle Platform Designed with Leading De...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница